Rx Medicare

This statement updates Members on latest developments in respect of the Influenza A (H1N1) swine flu pandemic. The latest GP consultation rates in Wales for flu-like illness have decreased and are now steady, although still a little above the usual rates for the time of year. On the 26th November, 77 people were in hospital with swine flu, 14 of those in critical care…

Read More…

Related Posts

• Welsh Assembly Government Written Statement On Swine Influenza, Wales
• Welsh Assembly Government Written Statement – Swine Influenza, Wales
• Welsh Assembly Government Encourages Parents To Have Children Under Five Vaccinated Against Swine Flu, Wales
• USDA Conducting Confirmatory Testing On Possible Detection Of 2009 Pandemic H1N1 Influenza In U.S. Swine
• Move From Daily To Weekly Welsh Assembly Government Swine Flu Reports, Wales
• VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine To Biological E.; Vaccine Could Become Available For Use In India This Year
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• Practice Fusion Identifies 300,000 High-Risk Patients For H1N1 Influenza Vaccine, In-line With CDC Pandemic Guidelines
• Japan Vaccinates Medical Workers Against Pandemic H1N1 Swine Flu
• Baxter Receives European Commission Approval For CELVAPAN H1N1 Pandemic Influenza Vaccine
• Baxter Receives EMEA Positive Opinion For CELVAPAN H1N1 Pandemic Influenza Vaccine
• European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
• Novel H1N1 Influenza A (Swine Flu) Update For Arkansans
• Latest Replikins Data Predicts Continued High Level Of H1N1 (Swine Flu) Infectivity And Lethality

Tags: assembly, developments, efficacy, government, h1n1, influenza, latest, pandemic, respect, statement, swine, welsh

This entry was posted on Wednesday, December 9th, 2009 at 2:12 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.